Abstract: The embodiments of the present application provide a method, apparatus and system for processing an image of a logistics parcel, which can capture an image with a barcode in a proper position. The method comprises: identifying a barcode in a Nth image to acquire position of the barcode in the Nth image, and placing the position into a queue; predicting a position that the barcode would locate in a (N+1)th image to be captured; identifying a barcode in the (N+1)th image to acquire position of the barcode relative to the (N+1)th image; determining whether the position of the barcode in the (N+1)th image matches with the predicted position; if so, placing the information of the barcode in the (N+1)th image into the queue; and after the parcel leaves the field of view, selecting, according to a preset optimal position of the barcode in an image and the information of the barcode placed into the queue, an optimal image from all images captured for the parcel.

Abstract: An emotion function chain may be generated from an email thread and displayed to a user in one or more windows on a computer display of a computer system. An email content analyzer may extract emotion indicators from the body of an email within the email thread. Using the emotion indicators, an attitude factor for an email may be determined. The attitude factors determined from each email within the email thread may be pictorially depicted in the emotion function chain. In response to a user interaction with a pictorial depiction of an attitude factor within the emotion function chain, a second window may generated to display the body of the email used to calculate the attitude factor interacted with.

Abstract: The present disclosure provided a blood cell analyzer, a control device and a blood analysis method thereof. In the method, a first reagent is mixed with a sample to obtain a first testing sample, and then a second reagent is mixed with the first testing sample for a further reaction to get a second testing sample for basophil classification and/or HGB measurement. A blood sample may be tested in one reaction cell through time-division multiplexing technology to obtain four groups leukocytes classification result and HGB result by single detection channel. Thus, the structure of the analyzer may be greatly simplified on the premise of guaranteeing the performance of the analyzer, the size and cost of the analyzer may reduce and a performance-price ratio of the analyzer may increase.

Abstract: A character recognition method and apparatus are disclosed, relate to the field of image recognition technologies, reduce a calculation time, and increase character recognition efficiency.

Abstract: There is provided a modeling method and device for a machine learning model. A machine learning sub-model corresponding to each intermediate target variable is trained to obtain a probability value of the machine learning sub-model. The probability values of the machine learning sub-models are summed to obtain a target probability value. A target machine learning model for determining a target behavior is established according to the target probability value and feature variables for describing transaction behaviors.

Abstract: The present disclosure provides multi-sampling model training methods and devices. One exemplary training method includes: performing multi-sampling on samples to obtain a training set and a validation set in each sampling; using the training set and the validation set obtained in each sampling as a group, and performing model training and obtaining a trained model using the training set in each group; evaluating the trained model using the training set and the validation set in each group separately; eliminating or retaining the trained model based on the evaluation results and a predetermined elimination criterion; obtaining prediction results of the samples using retained models; and obtaining a final model by performing combined model training on the retained models using the prediction results. The final model obtained using embodiments of the present disclosure can be more robust and stable, and can provide more accurate prediction results, thus greatly improving efficiency of modeling.

Abstract: An emotion function chain may be generated from an email thread and displayed to a user in one or more windows on a computer display of a computer system. An email content analyzer may extract emotion indicators from the body of an email within the email thread. Using the emotion indicators, an attitude factor for an email may be determined. The attitude factors determined from each email within the email thread may be pictorially depicted in the emotion function chain. In response to a user interaction with a pictorial depiction of an attitude factor within the emotion function chain, a second window may generated to display the body of the email used to calculate the attitude factor interacted with.

Abstract: Disclosed are a method and a system for video stitching. After it is determined that initial mounting of cameras in a M×N video stitching scene is completed, a reference image is selected from M×N images corresponding to M×N cameras; where both M and N are positive integers, at least one of M and N is larger than 1, and a rotating mirror is set in front of a camera lens of each camera; an image whose position does not meet a requirement among respective images except for the selected reference image is adjusted by controlling a rotating mirror corresponding to the image to rotate according to the selected reference image; and video stitching is performed according to an adjustment result.

Abstract: An emotion function chain may be generated from an email thread and displayed to a user in one or more windows on a computer display of a computer system. An email content analyzer may extract emotion indicators from the body of an email within the email thread. Using the emotion indicators, an attitude factor for an email may be determined. The attitude factors determined from each email within the email thread may be pictorially depicted in the emotion function chain. In response to a user interaction with a pictorial depiction of an attitude factor within the emotion function chain, a second window may generated to display the body of the email used to calculate the attitude factor interacted with.

Abstract: An emotion function chain may be generated from an email thread and displayed to a user in one or more windows on a computer display of a computer system. An email content analyzer may extract emotion indicators from the body of an email within the email thread. Using the emotion indicators, an attitude factor for an email may be determined. The attitude factors determined from each email within the email thread may be pictorially depicted in the emotion function chain. In response to a user interaction with a pictorial depiction of an attitude factor within the emotion function chain, a second window may generated to display the body of the email used to calculate the attitude factor interacted with.

Abstract: The present disclosure provided a blood cell analyzer, a control device and a blood analysis method thereof. In the method, a first reagent is mixed with a sample to obtain a first testing sample, and then a second reagent is mixed with the first testing sample for a further reaction to get a second testing sample for basophil classification and/or HGB measurement. A blood sample may be tested in one reaction cell through time-division multiplexing technology to obtain four groups leukocytes classification result and HGB result by single detection channel. Thus, the structure of the analyzer may be greatly simplified on the premise of guaranteeing the performance of the analyzer, the size and cost of the analyzer may reduce and a performance-price ratio of the analyzer may increase.

Abstract: Disclosed are a method and a system for video stitching. After it is determined that initial mounting of cameras in a M×N video stitching scene is completed, a reference image is selected from M×N images corresponding to M×N cameras; where both M and N are positive integers, at least one of M and N is larger than 1, and a rotating mirror is set in front of a camera lens of each camera; an image whose position does not meet a requirement among respective images except for the selected reference image is adjusted by controlling a rotating mirror corresponding to the image to rotate according to the selected reference image; and video stitching is performed according to an adjustment result.

Abstract: Methods of processing inactivated artificial antigen presenting cells (aAPCs) and artificial antigen presenting cells with specificity for selected antigenic peptides are described, including their generation and use in cell therapy compositions comprising activated cytotoxic T lymphocytes. Inactivated aAPCs are advantageously generated through crosslinking, such as via a photoreaction involving a psoralen derivative and UVA irradiation.

Abstract: Multiple myeloma (MM) is a clonal B cell malignancy and remains essentially incurable by conventional anti-tumor therapy. Patients with MM have a median survival of only three years. MM is characterized by proliferation and accumulation of mature plasma cells in the bone marrow (BM) leading to bone destruction, BM failure, anemia, and reduced immune function. The identification of MHC Class I, HLA-A2, associated peptides presented on multiple myeloma cells is an important step in developing immunotherapies for MM. Presented here are methods for creating activated T lymphocytes that are cytotoxic to both peptide loaded T2 target cells and multiple myeloma cell lines.

Abstract: Multiple myeloma (MM) is a clonal B cell malignancy and remains essentially incurable by conventional anti-tumor therapy. Patients with MM have a median survival of only three years. MM is characterized by proliferation and accumulation of mature plasma cells in the bone marrow (BM) leading to bone destruction, BM failure, anemia, and reduced immune function. The identification of MHC Class I, HLA-A2, associated peptides presented on multiple myeloma cells is an important step in developing immunotherapies for MM. Presented here are methods for creating activated T lymphocytes that are cytotoxic to both peptide loaded T2 target cells and multiple myeloma cell lines.

Abstract: Multiple myeloma (MM) is a clonal B cell malignancy and remains essentially incurable by conventional anti-tumor therapy. Patients with MM have a median survival of only three years. MM is characterized by proliferation and accumulation of mature plasma cells in the bone marrow (BM) leading to bone destruction, BM failure, anemia, and reduced immune function. The identification of MHC Class I, HLA-A2, associated peptides presented on multiple myeloma cells is an important step in developing immunotherapies for MM. Presented here are methods for creating activated T lymphocytes that are cytotoxic to both peptide loaded T2 target cells and multiple myeloma cell lines.

Abstract: Methods of processing inactivated artificial antigen presenting cells (aAPCs) and artificial antigen presenting cells with specificity for selected antigenic peptides are described, including their generation and use in cell therapy compositions comprising activated cytotoxic T lymphocytes. Inactivated aAPCs are advantageously generated through crosslinking, such as via a photoreaction involving a psoralen derivative and UVA irradiation.

Abstract: Cytotoxic T lymphocytes (CTLs) specific for antigenic peptides derived from IgE molecule can be generated in vitro by stimulating resting naive CD8 T cells with IgE peptides presented by artificial antigen presenting cells. The IgE specific CTLs lyse the target cells loaded with IgE peptides in vitro and inhibit antigen specific IgE response in vivo. In addition, adoptive transfer of the IgE specific CTL to an asthmatic mouse model can inhibit the development of lung inflammation and airway hypersensitivity. IgE specific CTL provides a treatment for allergic asthma and other IgE-mediated allergic diseases. Antigenic peptides identified from non-tumor self-antigens induce specific cytotoxic T lymphocyte (CTL) in vitro. The CTL induced by peptides identified from CD40L can kill activated CD4 T cells. In vitro generated CTL specific for CD40L inhibit CD4-dependent antibody responses of all isotypes in vivo.

Abstract: Cytotoxic T lymphocytes (CTLs) specific for antigenic peptides derived from IgE molecule can be generated in vitro by stimulating resting naive CD8 T cells with IgE peptides presented by artificial antigen presenting cells. The IgE specific CTLs lyse the target cells loaded with IgE peptides in vitro and inhibit antigen specific IgE response in vivo. In addition, adoptive transfer of the IgE specific CTL to an asthmatic mouse model can inhibit the development of lung inflammation and airway hypersensitivity. IgE specific CTL provides a treatment for allergic asthma and other IgE-mediated allergic diseases. Antigenic peptides identified from non-tumor self-antigens induce specific cytotoxic T lymphocyte (CTL) in vitro. The CTL induced by peptides identified from CD40L can kill activated CD4 T cells. In vitro generated CTL specific for CD40L inhibit CD4-dependent antibody responses of all isotypes in vivo.

Abstract: Cytotoxic T lymphocytes (CTLs) specific for antigenic peptides derived from IgE molecule can be generated in vitro by stimulating resting naive CD8 T cells with IgE peptides presented by artificial antigen presenting cells. The IgE specific CTLs lyse the target cells loaded with IgE peptides in vitro and inhibit antigen specific IgE response in vivo. In addition, adoptive transfer of the IgE specific CTL to an asthmatic mouse model can inhibit the development of lung inflammation and airway hypersensitivity. IgE specific CTL provides a treatment for allergic asthma and other IgE-mediated allergic diseases. Antigenic peptides identified from non-tumor self-antigens induce specific cytotoxic T lymphocyte (CTL) in vitro. The CTL induced by peptides identified from CD40L can kill activated CD4 T cells. In vitro generated CTL specific for CD40L inhibit CD4-dependent antibody responses of all isotypes in vivo.